Progress of structurally diverse cereblon (CRBN) ligands and their application in PROTAC degraders
Bioorganic Chemistry · 2026-08 · 178 · 109968
DOI: 10.1016/j.bioorg.2026.109968 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioorganic Chemistry, 2026-08. Verfasst von Shuguang Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Engineering, School of Chemical Engineering, Northwest University, 229 Taibai North Road, Xi'an 710069, China. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 195 Literaturangaben. Gefördert von: Shaanxi Science and Technology Association, Education Department of Shaanxi Province, Shaanxi Province Natural Science Foundation.
Abstract (Originalsprache)
Protein degradation-targeting chimeras (PROTACs) degrade target proteins by hijacking the ubiquitin-proteasome pathway, and their unique mechanism of action has attracted great attention from the scientific community over the past decade. In recent years, the field has achieved significant advancements, mainly due to the advent of various E3 ligase ligands and their prevalent application in the design of PROTACs. To date, more than ten E3 ligases have been exploited for the development of PROTACs. Notably, recruiting cereblon (CRBN) represents one of the most widely reported strategies in PROTAC design, attributed to the widespread expression across various tissues of CRBN and the favorable drug-like characteristics and synthetic accessibility of classical CRBN ligands, immunomodulatory imide drugs (IMiDs). Nevertheless, IMiDs face significant challenges, including inducing neo-substrate degradation, inherent racemization, and readily undergoing hydrolysis. In recent years, numerous structurally diverse CRBN ligands with enhanced selectivity and stability have been synthesized for the development of PROTACs. This review provides a systematic overview of the development of CRBN ligands with distinct structural scaffolds reported in peer-reviewed literature, focusing on activity optimization processes, structure-activity relationship investigations, and their practical applications in PROTACs design. Additionally, we further summarize conditionally activated CRBN-based PROTACs with reduced off-target toxicity. The aim is to offer both practical insights and innovative perspectives for future investigations in this fast-evolving field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Engineering, School of Chemical Engineering, Northwest University, 229 Taibai North Road, Xi'an 710069, China.
- Department of Pharmaceutical Engineering, School of Chemical Engineering, Northwest University, 229 Taibai North Road, Xi'an 710069, China. Electronic address: liuqc21@nwu.edu.cn.
- Department of Pharmaceutical Engineering, School of Chemical Engineering, Northwest University, 229 Taibai North Road, Xi'an 710069, China; Engineering Research Center of Western Resource Innovation Medicine Green Manuf…
- Department of Pharmaceutical Engineering, School of Chemical Engineering, Northwest University, 229 Taibai North Road, Xi'an 710069, China. Electronic address: xuying@nwu.edu.cn.
Förderung
- Shaanxi Science and Technology Association
- Education Department of Shaanxi Province
- Shaanxi Province Natural Science Foundation
Zitieren
APA
Yang, S., Zhang, Y., Song, X., Liu, Q., Fan, D., & Xu, Y. (2026). Progress of structurally diverse cereblon (CRBN) ligands and their application in PROTAC degraders. Bioorganic Chemistry, 178, 109968. https://doi.org/10.1016/j.bioorg.2026.109968
Vancouver
Yang S, Zhang Y, Song X, Liu Q, Fan D, Xu Y. Progress of structurally diverse cereblon (CRBN) ligands and their application in PROTAC degraders. Bioorganic Chemistry. 2026;178:109968. doi:10.1016/j.bioorg.2026.109968
BibTeX
@article{Yang2026,
author = {Yang, Shuguang and Zhang, Yanxin and Song, Xiaoping and Liu, Qingchao and Fan, Daidi and Xu, Ying},
title = {Progress of structurally diverse cereblon (CRBN) ligands and their application in PROTAC degraders},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {178},
pages = {109968},
doi = {10.1016/j.bioorg.2026.109968}
}
EUVIMED